161 results
Page 5 of 9
8-K
EX-99.1
jylu9e6s6aken5h1
7 Aug 19
Intra-Cellular Therapies Provides Corporate Update and Reports Second Quarter 2019 Financial Results
8:08am
8-K
EX-99.1
9i55w6jrs f4
5 Aug 19
Intra-Cellular Therapies to Host Conference Call to Provide Regulatory Update Following Recent Meeting with FDA
7:37am
8-K
EX-99.1
2hq3r3
24 Jul 19
Intra-Cellular Therapies Provides Update on FDA Advisory Committee Meeting for Lumateperone for the Treatment of Schizophrenia
6:07am
8-K
EX-99.1
bsq s6g27c699
8 Jul 19
Intra-Cellular Therapies Announces PositiveTop-line Results from a Phase 3 Trial of Lumateperone in Patients with Bipolar Depression
7:10am
DEFA14A
9gvp3rc
14 Jun 19
Additional proxy soliciting materials
4:31pm
8-K
EX-99.1
vi5xe670thj594z
8 May 19
Intra-cellular Therapies Reports First Quarter 2019 Financial Results and Provides Corporate Update
7:35am
8-K
EX-99.1
t4vqtxgbqgfydk31
27 Feb 19
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2018 Financial Results and Provides Corporate Update
7:43am
8-K
EX-99.1
8hpbfxhox2 5iy02p
18 Dec 18
Intra-Cellular Therapies Announces Update onITI-007-201 Clinical Trial for Treatment of Agitation in Patients with Probable Alzheimer’s Disease
8:39am
8-K
d5ufwujly oohr
12 Dec 18
Other Events
7:02am
8-K
EX-99.1
0av84ebprc9jwd25y
12 Dec 18
Other Events
7:02am
8-K
EX-99.1
mi003
11 Dec 18
Intra-Cellular Therapies Announces FDA Acceptance of New Drug Application for Lumateperone for the Treatment of Schizophrenia
7:15am
8-K
EX-99.1
pyglgg funui1ux08
7 Nov 18
Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2018 Financial Results
7:17am